STEVEN PRESTRELSKI

Insider Reports History

Location
Chicago, IL
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEVEN PRESTRELSKI:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Chief Scientific Officer Common Stock 719,780 $1,345,989 $1.87 31 Jan 2023 Direct
XERIS PHARMACEUTICALS INC Chief Scientific Officer Common Stock 0 05 Oct 2021 Direct
XERIS PHARMACEUTICALS INC Chief Scientific Officer Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by STEVEN PRESTRELSKI

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 31 Jan 2023 1 $0 4 Chief Scientific Officer 01 Feb 2023, 15:12
XERS Xeris Biopharma Holdings, Inc. 22 Feb 2022 3 -$19,411 4 Chief Scientific Officer 24 Feb 2022, 15:28
XERS Xeris Biopharma Holdings, Inc. 03 Jan 2022 1 $0 4 Chief Scientific Officer 05 Jan 2022, 17:15
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 8 $0 4 Chief Scientific Officer 05 Oct 2021, 19:46
XERS XERIS PHARMACEUTICALS INC 05 Oct 2021 8 $0 4 Chief Scientific Officer 05 Oct 2021, 17:34
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Chief Scientific Officer 05 Oct 2021, 17:16